Furthermore, a significant increase in the mRNA expression levels of ROCK2 was found 35 days after CCH injury (P < 0.01 vs. control), while RES administration did not show any significant difference in the CCH + RES group compared to the CCH group. The gene discussed is ROCK2; the disease is columnar cell hyperplasia of the breast.